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Fanconi anemia (FA; MIM no. 227650), the most com-
monly inherited bone marrow disorder, has an overall
prevalence of 1–5 per million and an estimated carrier
frequency of 1:200-300 in most populations. Demon-
strating either an autosomal or X-linked recessive mode
of inheritance, FA is characterized by childhood pro-
gressive bone marrow failure and predisposition to
acute myelogenous leukemia, older patients are at
increased risk for squamous cell carcinomas of the head,
neck, and genitourinary tract. Congenital abnormalities
are present in approximately 70% of FA patients and
may include radial ray defects, cafe´ au lait spots or
hypopigmentation, short stature, microphthalmia, mal-
formations of kidneys, gastrointestinal tract, and heart,
mental retardation, and hearing defects. Because of the
high degree of phenotypic variability exhibited by FA
patients, diagnosis may be difficult on the basis of clini-
cal manifestations alone. Because FA patient-derived
lymphocytes and fibroblasts exhibit hypersensitivity to
DNA crosslinking agents such as diepoxybutane (DEB)
and mitomycin C (MMC), resulting in a high rate of
chromosomal breakage and radial formation, analysis on
the basis of this hypersensitivity has been routinely used
to confirm clinical diagnosis.
Molecular diagnosis of FA has been challenging
because of the genetic heterogeneity associated with the
disease. To date, 15 FA gene products (FANCA, B, C,
D1, D2, E, F, G, I, J, L, M, N, O and P) have been iden-
tified and they constitute the FANC pathway, which is
thought to function in preventing genome instability.
The FA core complex comprises FAAP24, FAAP100,
and 8 FA proteins (FANCA, B, C, E, F, G, L, and M)
and mediates DNA-damage-induced or replication-stress
induced monoubiquitylation of FANCD2 and FANCI.
Monoubiquitinated FANCD2 and FANCI translocate to
chromatin and function in DNA repair at least partially
by recruitment of FAN1 nuclease. Cloning of the FANC
genes has provided a means, via complementation group
analysis, to routinely pinpoint the patient’s specific FA
gene harboring the mutations, thus greatly simplifying
subsequent molecular analysis. Although retroviral-
mediated complementation analysis of FA patient-
derived cells is commonly used to identify the patient’s
genetic subtype as a prerequisite for mutation screening,
such analysis has not been formally validated for clinical
use. Previous studies have considered Fanconi comple-
mentation Group A (FA-A) assignments, but none have
performed comprehensive sequencing to verify comple-
mentation assignment and/or evaluated complementa-
tion assignments performed using retroviral-mediated
rescue as evidenced by correction of MMC and DEB-
induced chromosome breakage and radial formation.
Among all complementation groups, FAA accounts for
the majority of FA patients (60–65%) followed by FAC
(10%) and FAG (9%). Mutations in the gene for comple-
mentation group FA-A (FANCA; MIM no. 607139) con-
fer autosomal recessive inheritance and account for
approximately 66% of all FA cases. The FANCA gene is
mapped to chromosome 16q24.3,11 spans approximately
80 kb of genomic DNA (gDNA), and consists of 43
exons. With more than 200 different mutations
described thus far, the FANCA mutation spectrum is
very heterogeneous. Because of the presence of a large
number of Alu repeat sequences within the FANCA
gene, large intragenic deletions involving multiple exons
have been reported to account for more than 40% of all
FANCA mutations.
First time we have carried out a molecular study in
the Indian population. We have studied FA by chromo-
somal breakage study using mitomycin C (MMC) andCorrespondence: vbaburao@hotmail.com
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diepoxybutane (DEB) induction and FANCD2 monoubi-
quitination by western blotting to understand gene
defects in FA pathway. The complementation analysis
was done by retroviral transfection. The molecular study
was carried out by Multiplex Ligation-dependent Probe
Amplification (MLPA) and direct sequencing of
FANCA, C, G, E, F, L, and M genes. The complementa-
tion analysis results showed different spectrum as com-
pared to world literature. Our study revealed FA-A and
E gene defects in 69% cases and followed by FANCE
gene defect. The molecular analysis showed the large
deletions in 11 patients and FANCA gene mutations
were in 12 FA patients. Out of 12 mutations 5 mutations
(c.3678 C>G, p.Ser 1226 X, c.3993G>A p.Leu 1331 Pro,
c.1274 C>G p.Glu 425 His, c.2630 C>G p.Ser 877 X)
found to be novel mutations. In our series the single
nucleotide polymorphisms (SNP); Exon9,c.796A>G(p.
Thr266Ala), Exon16,c.1501G>A(p.Gly501Ser), Exon26,
c.2426G>A(p.Gly809Asp), of FANCA gene also observed
in 23 patients, and these polymorphisms in disease asso-
ciation was reported in FA database, however, it needs to
be established in Indian population. Interesting finding of
our study is the existence of FANCE mutation in Indian
population, and the same was reported rarely in other
places of the world. The study also highlighted the
uncharacterized FA patients, which may associated with
new genes in Indian population and these patients should
be studied molecularly and genotype-phenotype correla-
tion need to be established, which helps in better under-
standing and management of the disease.
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